Zhonghua Yi Xue Za Zhi. 2023 Feb 7;103(5):329-335. doi: 10.3760/cma.j.cn112137-20220817-01749.
Recently, the percutaneous endoscopic lumbar interbody fusion (PELIF) technique has become the most representative minimally invasive technique in spinal surgery. PELIF is widely used in the treatment of various degenerative diseases of the lumbar spine. However, this technique has a long learning curve with adverse consequences for the patient if the surgeon is unsure of the indications and contraindications of this technique. There is currently no expert consensus on PELIF in spinal surgery in China. To standardize the application of this technique in various diseases of the lumbar spine in China, the Chinese Study Group of Minimal Invasive Spinal Surgery, Chinese Association of Spine and Spinal Cord, and Chinese Study Group for Lumbar Spine, Chinese Association of Spine and Spinal Cord, of the Chinese Association of Rehabilitation Medicine have taken the lead in developing this Chinese expert consensus on the application PELIF through a modified Delphi survey study method for the reference of our colleagues. The consensus covers the following aspects of the PELIF: indications and contraindications, advantages and disadvantages, preoperative evaluation, anesthesia methods and surgical procedures, treatment and prevention of complications, and postoperative follow-up.
近年来，经皮内镜下腰椎椎间融合术（PELIF）已成为脊柱外科最具代表性的微创技术。PELIF广泛应用于各种腰椎退行性疾病的治疗。然而，该技术学习曲线较长，如果外科医生对其适应证和禁忌证把握不准，会给患者带来不良后果。目前我国脊柱外科领域对于PELIF尚无专家共识。为规范该技术在我国腰椎各类疾病中的应用，中国康复医学会脊柱脊髓专业委员会微创脊柱外科学组、中华医学会骨科学分会脊柱外科学组腰椎学组牵头，通过改良德尔菲调查研究方法制定了本中国PELIF应用专家共识，供同行参考。本共识涵盖了PELIF的适应证与禁忌证、优缺点、术前评估、麻醉方式及手术步骤、并发症的处理与预防以及术后随访等方面。
